Navigation Links
Drug Reduces Risk of Clogged Arteries, Veins

The blood-thinning drug fondaparinux (Arixta) nearly halves the risk of potentially deadly deep vein thrombosis and pulmonary embolism in people hospitalized with congestive heart failure, chronic respiratory disease and other conditions that increase the risk of these conditions, claims a new study.
People treated with the drug were 47 percent less likely to suffer venous thromboembolism (a condition involving clotting or obstruction of a vein that includes both deep vein thrombosis and pulmonary embolism) than people who received a placebo,// according to the study results. In the group taking fondaparinux, 5.6 percent had venus thromboembolism events, compared with 10.5 percent of the people in the placebo group.

The study also found that the drug reduced fatal pulmonary embolisms and showed a trend toward reducing overall death - 3.3 percent in the study group compared with 6 percent in the placebo group. The incidence of bleeding in both groups was 0.2 percent.
'"/>




Page: 1

Related medicine news :

1. Sunshine Reduces MS Risk
2. Estrogen in Food Reduces Cancer Risk
3. Dental Procedure Reduces Preterm Births
4. Vaccine Reduces antibiotic-resistant infections in Children
5. Eating Fiber Reduces The Risk Of Heart Disease
6. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
7. Anti-tobacco Advertising Can Reduces smoking Among Teens
8. Eating Fish Reduces Heart Disease
9. Co-trimoxazole Use Reduces Childhood AIDS –Related Death
10. NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks
11. Oxytocin Boosts Trust and Reduces Fear.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ORLEANS, La. (PRWEB) , ... July 21, 2017 ... ... to allow 4th-year medical students improve their chances of acceptance to a residency ... for those who have earned degrees outside the U.S. , According to data ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital ... adjustable beds used in such facilities are specially designed to accommodate patients with a ... , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, ...
(Date:7/20/2017)... MD (PRWEB) , ... July 20, 2017 , ... ... company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary ... million. , Proceeds will be used to complete regulatory submissions and fund final ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences Inc. ... to support the development of CRISPR-Cas3 antimicrobial therapeutics. Financing ... a leading Chinese Internet services provider, and joined by ... multiple infectious disease product programs targeting antibiotic resistant infections ... Founded by Dr. Rodolphe Barrangou and ...
(Date:7/5/2017)... a company of over 2,000 employees and a leader in environmental and life ... solidifying their position as the top American owned and operated environmental testing firm ... ... ... TN , enhances Pace Analytical,s capability as an innovative full service provider ...
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the ... The research describes the use of its AVACEN Treatment Method ... suffering from fibromyalgia. ... AVACEN Medical ... characterized by chronic widespread pain. It affects approximately 200 to 400 million ...
Breaking Medicine Technology: